Zenas BioPharma Income Statement (2023-2026) | ZBIO

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 50.00M5.00M10.00M
Operating items
Research & Development (Quarter) 9.35M20.42M22.64M33.81M33.53M49.16M34.91M43.03M34.40M55.72M60.44M
Selling, General & Administrative (Quarter) 5.02M4.36M4.93M5.89M7.45M11.47M12.41M12.14M13.18M15.59M16.91M
Other Operating Expenses (Quarter) 5.00M166.67M
Operating Expenses (Quarter) 14.38M24.78M27.58M39.70M40.98M60.62M47.33M55.16M52.58M237.98M77.35M
Operating Income (Quarter) 35.62M-24.78M-27.58M-39.70M-40.98M-55.62M-37.33M-55.16M-52.58M-237.98M-77.35M
EBIT (Quarter) 35.62M-24.78M-27.58M-39.70M-40.98M-55.62M-37.33M-55.16M-52.58M-237.98M-77.35M
Non-operating items
Interest & Investment Income (Quarter) 3.39M3.02M
Other Non Operating Income (Quarter) -0.02M0.79M0.47M1.88M2.38M-4.53M0.16M2.96M1.08M-7.18M-0.02M
Non Operating Income (Quarter) -0.02M0.79M0.47M1.73M2.38M-3.68M0.16M2.96M1.08M-2.35M-3.64M
Net income details
EBT (Quarter) 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.78M-52.20M-51.50M-251.03M-80.99M
Tax Provisions (Quarter) -0.20M0.02M0.11M
Profit After Tax (Quarter) 35.61M-24.60M-27.80M-37.98M-38.60M-52.59M-33.57M-52.22M-51.50M-240.44M-80.99M
Income from Continuing Operations (Quarter) 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.57M-52.22M-51.50M-251.13M-80.99M
Consolidated Net Income (Quarter) 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.57M-52.22M-51.50M-251.13M-80.99M
Income towards Parent Company (Quarter) 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.57M-52.22M-51.50M-251.13M-80.99M
Net Income towards Common Stockholders (Quarter) 35.62M-24.78M-27.80M-37.98M-38.61M-56.53M-33.57M-52.22M-51.50M-251.13M-80.99M
Additional items
EPS (Basic) (Quarter) 2.42-16.04-17.89-24.23-5.0216.94-0.80-1.25-1.22-5.17-1.46
EPS (Weighted Average and Diluted) (Quarter) 1.96-16.04-17.89-24.23-5.0216.94-0.80-1.25-1.22-5.17-1.46
Shares Outstanding (Weighted Average) (Quarter) 1.54M1.53M1.55M1.56M7.70M13.20M41.80M41.83M41.94M44.73M55.62M
Shares Outstanding (Diluted Average) (Quarter) 1.53M1.55M1.57M3.62M13.20M41.80M41.87M41.94M44.73M55.62M
EBITDA (Quarter) 35.62M-24.67M-27.76M-37.95M-38.66M-52.46M-33.63M-52.46M-51.47M-240.44M-81.30M
Interest Expenses (Quarter) 0.37M
Tax Rate (Quarter) 0.61%-0.04%-0.04%